Association of Low High-Density Lipoprotein Cholesterol Levels with Poor Outcomes in Hepatitis B-Associated Decompensated Cirrhosis Patients
Table 1
Patient characteristics at baseline.
All patients ()
Surviving patients ()
Nonsurviving patients ()
Gender (female/male)
30/123
22/102
8/21
0.346
Age (years)
53.0 (46.0-63.0)
53.0 (46.0-63.0)
55.0 (47.8-61.5)
0.952
Total protein (g/L)
61.5 (56.5-66.8)
61.7 (57.8-67.2)
59.4 (52.4-65.9)
0.098
Albumin (g/L)
30.6 (26.4-34.6)
31.4 (27.4-35.1)
28.9 (23.7-31.2)
0.011
Alanine aminotransferase (U/L)
29.0 (16.0-43.0)
28.0 (15.5-39.0)
38.0 (22.3-57.0)
0.102
Aspartate aminotransferase (U/L)
42.0 (27.8-71.0)
40.5 (27.0-63.5)
54.0 (31.8-97.5)
0.038
Serum creatinine (μmol/L)
74.0 (61.0-87.0)
73.5 (61.0-84.0)
92.0 (61.8-124.0)
0.065
Total bilirubin (μmol/L)
36.0 (17.8-83.3)
31.5 (16.0-59.0)
117.0 (64.8-212.5)
<0.001
Blood urea nitrogen (μmol/L)
5.8 (4.3-7.7)
5.5 (4.2-7.4)
7.2 (5.8-12.9)
0.002
INR
1.34 (1.18-1.61)
1.30 (1.16-1.51)
1.67 (1.50-1.90)
<0.001
HDL-C (mmol/L)
0.73 (0.45-1.07)
0.82 (0.57-1.20)
0.40 (0.16-0.62)
<0.001
Platelet (×109/L)
66.0 (40.8-120.3)
65.5 (39.5-113.0)
72.0 (59.3-159.3)
0.208
Hemoglobin (g/L)
101.0 (84.0-117.3)
103.5 (83.5-118.0)
94.0 (87.5-113.3)
0.407
MELD score
11.4 (6.8-16.8)
9.9 (6.0-13.7)
19.7 (15.4-22.5)
<0.001
Data are expressed as number or median (interquartile range). Abbreviations: INR: international normalized ratio; HDL-C: high-density lipoprotein cholesterol; MELD: Model for End-stage Liver Disease.
